Anavex Life Sciences Corp. Acquires A Portfolio Of Patents And Appoints Dr. Alexandre Vamvakides As CSO And Director

KELOWNA, BRITISH COLUMBIA -- (MARKET WIRE) -- January 31, 2007 -- Anavex Life Sciences Corp. (OTCBB: AVXL) (the "Company") announces that it has acquired a portfolio of three patents and one patent application covering drug candidates indented to be further developed through commercialization targeting the areas of neurological diseases and cancer. The patents were assigned by Dr. Alexandre Vamvakides, of Paris, France, who has been appointed as Chief Scientific Officer and member of the Board of Directors.